HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases

BACKGROUND: For chronic hepatitis B (CHB) patients without willingness to extend the routine duration of interferon (IFN) therapy, it is important to identify patients who will benefit from treatment cessation. Hepatitis B surface antigen (HBsAg) quantification is recommended for management of IFN t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuai, Luo, Wenfan, Wu, Yin, Chen, Hongjie, Peng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171920/
https://www.ncbi.nlm.nih.gov/pubmed/32316928
http://dx.doi.org/10.1186/s12876-020-01263-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171920/
https://www.ncbi.nlm.nih.gov/pubmed/32316928
http://dx.doi.org/10.1186/s12876-020-01263-6

Ejemplares similares